|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
EP0216846B2
(en)
|
1985-04-01 |
1995-04-26 |
Celltech Limited |
Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
GB9818110D0
(en)
|
1998-08-19 |
1998-10-14 |
Weston Medical Ltd |
Needleless injectors and other devices
|
|
US6096002A
(en)
|
1998-11-18 |
2000-08-01 |
Bioject, Inc. |
NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method
|
|
US7083784B2
(en)
|
2000-12-12 |
2006-08-01 |
Medimmune, Inc. |
Molecules with extended half-lives, compositions and uses thereof
|
|
US7658921B2
(en)
|
2000-12-12 |
2010-02-09 |
Medimmune, Llc |
Molecules with extended half-lives, compositions and uses thereof
|
|
US7217797B2
(en)
|
2002-10-15 |
2007-05-15 |
Pdl Biopharma, Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
|
WO2005037867A1
(en)
|
2003-10-15 |
2005-04-28 |
Pdl Biopharma, Inc. |
ALTERATION OF Fc-FUSION PROTEIN SERUM HALF-LIVES BY MUTAGENESIS OF POSITIONS 250, 314 AND/OR 428 OF THE HEAVY CHAIN CONSTANT REGION OF IG
|
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
CN106029697B
(zh)
|
2013-12-20 |
2021-06-04 |
英特维特国际股份有限公司 |
具有经修饰的ch2-ch3序列的犬抗体
|
|
US20200181258A1
(en)
|
2016-10-17 |
2020-06-11 |
Vetoquinol Sa |
Modified antibody constant region
|
|
IL276286B2
(en)
|
2018-01-26 |
2025-07-01 |
Genzyme Corp |
FC variants with improved binding to FCRN and extended half-life
|
|
US20210388053A1
(en)
|
2018-10-18 |
2021-12-16 |
Kindred Biosciences, Inc. |
Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use
|
|
JP7536294B2
(ja)
*
|
2018-12-05 |
2024-08-20 |
株式会社バイカ・セラピュティクス |
抗体のＦｃ領域改変体
|
|
CN113544153B
(zh)
|
2019-01-03 |
2024-12-10 |
因外泰克斯公司 |
用于增加治疗剂在犬中的半衰期的组合物及使用方法
|
|
US20220169740A1
(en)
|
2019-03-20 |
2022-06-02 |
Kindred Biosciences, Inc. |
NGF Antagonists for Medical Use
|
|
FR3104217B1
(fr)
|
2019-12-10 |
2021-12-24 |
Innov Shoes |
Dispositif d’assemblage amovible entre deux pièces
|
|
MX2022007676A
(es)
*
|
2019-12-20 |
2022-07-19 |
Intervet Int Bv |
Anticuerpos caninizados biespecificos para tratar dermatitis atopica.
|
|
CN120590527A
(zh)
|
2020-05-11 |
2025-09-05 |
因外泰克斯公司 |
用于增加治疗剂在犬中的半衰期的组合物和使用方法
|